VAMP-1 Activators
The chemical class of VAMP-1 activators comprises a diverse array of compounds that exert their influence on the protein through direct or indirect mechanisms. These activators offer valuable insights into the intricate regulation of synaptic vesicle exocytosis, a process fundamental to neurotransmitter release. One prominent activator is Forskolin, which indirectly enhances VAMP-1 function by stimulating adenylate cyclase, leading to elevated cAMP levels and subsequent activation of PKA. This cascade of events modulates cellular processes associated with VAMP-1, providing a pharmacological avenue to augment neurotransmitter release. Another notable activator is Glutamate, which directly influences VAMP-1 by binding to ionotropic glutamate receptors, triggering an increase in intracellular calcium levels. This calcium influx directly impacts vesicle fusion and neurotransmitter release, highlighting the specific and direct activation of VAMP-1 by Glutamate. Additionally, Resveratrol showcases indirect activation by influencing SIRT1, a NAD+-dependent deacetylase. This modulation can lead to deacetylation events impacting cellular processes associated with synaptic vesicle exocytosis, indirectly enhancing VAMP-1 function.
Other activators in the class, such as Ropinirole, PMA, and Quercetin, exemplify the diverse approaches to modulating VAMP-1. Ropinirole indirectly activates VAMP-1 by influencing dopaminergic signaling pathways, showcasing the interconnectedness of neurotransmitter systems in regulating synaptic vesicle exocytosis. PMA, through the activation of PKC, and Quercetin, by influencing various cellular pathways, further underscore the multifaceted nature of VAMP-1 regulation. In summary, the chemical class of VAMP-1 activators provides a rich palette of compounds with distinct mechanisms of action, offering researchers versatile tools to dissect the complexities of neurotransmitter release.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates VAMP-1 indirectly by stimulating adenylate cyclase, leading to an increase in intracellular cAMP levels. Elevated cAMP activates protein kinase A (PKA), which in turn modulates cellular processes influencing VAMP-1 function. Forskolin, by activating this signaling cascade, provides a pharmacological approach to enhance neurotransmitter release through the modulation of VAMP-1 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates VAMP-1 indirectly by influencing SIRT1, a nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase. SIRT1 activation by Resveratrol can lead to deacetylation events that impact cellular processes associated with synaptic vesicle exocytosis. The indirect modulation of VAMP-1 by Resveratrol highlights the potential of targeting cellular pathways to enhance neurotransmitter release. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate acts as a direct activator of VAMP-1 by binding to ionotropic glutamate receptors, leading to an increase in intracellular calcium levels. Elevated calcium triggers vesicle fusion and neurotransmitter release, directly modulating VAMP-1 function. The direct activation of VAMP-1 by Glutamate underscores the importance of neurotransmitter-mediated regulation in synaptic vesicle exocytosis. | ||||||
Ropinirole Hydrochloride | 91374-20-8 | sc-205843 sc-205843A | 25 mg 100 mg | $84.00 $317.00 | 1 | |
Ropinirole, an agonist of dopamine receptors, indirectly activates VAMP-1 by modulating dopaminergic signaling pathways. The activation of dopamine receptors can lead to downstream cellular events that influence VAMP-1 function, providing a pharmacological avenue to enhance neurotransmitter release. The indirect modulation of VAMP-1 by Ropinirole highlights the interconnectedness of neurotransmitter systems in regulating synaptic vesicle exocytosis. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates VAMP-1 indirectly by stimulating protein kinase C (PKC), which can influence cellular processes associated with synaptic vesicle exocytosis. PKC activation by PMA leads to phosphorylation events that impact the activity of proteins involved in vesicle fusion, indirectly modulating VAMP-1 function. The activation of PKC by PMA provides a pharmacological approach to enhance neurotransmitter release through the modulation of VAMP-1 activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin activates VAMP-1 indirectly by influencing cellular pathways associated with synaptic vesicle exocytosis. As a flavonoid with diverse cellular effects, Quercetin can modulate signaling pathways and cellular processes that impact VAMP-1 function. The indirect activation of VAMP-1 by Quercetin highlights its potential as a natural compound to enhance neurotransmitter release by targeting multiple cellular mechanisms. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644 activates VAMP-1 indirectly by enhancing calcium influx through L-type voltage-gated calcium channels. Increased intracellular calcium levels, facilitated by Bay K 8644, directly influence vesicle fusion and neurotransmitter release, providing a pharmacological approach to enhance VAMP-1-mediated exocytosis. The indirect modulation of VAMP-1 by Bay K 8644 underscores the role of calcium dynamics in regulating synaptic vesicle exocytosis. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $38.00 $1155.00 $122.00 | 3 | |
4-Aminopyridine activates VAMP-1 indirectly by influencing potassium channels, leading to increased depolarization and calcium influx. The modulation of potassium channels by 4-Aminopyridine indirectly impacts cellular processes associated with VAMP-1 function, providing a pharmacological avenue to enhance neurotransmitter release. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram activates VAMP-1 indirectly by inhibiting phosphodiesterase type 4 (PDE4), leading to an increase in intracellular cAMP levels. Elevated cAMP activates PKA, which can influence cellular processes associated with VAMP-1 function. The indirect modulation of VAMP-1 by Rolipram provides a pharmacological approach to enhance neurotransmitter release through the regulation of cAMP-dependent signaling pathways. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine activates VAMP-1 indirectly by modulating cellular processes associated with synaptic vesicle exocytosis. As a derivative of the alkaloid vincamine, Vinpocetine can influence signaling pathways and ion channel dynamics that impact VAMP-1 function. | ||||||